GlassScriptPhysician profile
Shelley Rae Morrison
NPI 1801353024
$455.78
in general payments reported to CMS, 2019-2025
10 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $77.40 · 2023: $95.97 · 2024: $140 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $378.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $122.87 | 2024-2025 | Rezdiffra, Resmetirom |
| Abbvie INC. | $94.86 | 2022-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.32 | 2023-2024 | Xifaxan |
| Medtronic, INC. | $46.79 | 2024-2025 | Bravo, Manoscan |
| Aveo Pharmaceuticals, INC. | $41.16 | 2023 | Fotivda |
| Glaxosmithkline, LLC. | $27.02 | 2025 | |
| Davol INC. | $22.56 | 2024 | Arista Ah Flexitip |
| Hologic Sales and Service, LLC | $17.10 | 2023 | Fluent Fluid Management System |
| Kyowa Kirin, INC. | $16.20 | 2023 | Poteligeo |
| Dexcom, INC. | $15.90 | 2024 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shelley Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.